Have a personal or library account? Click to login
Gender impact on quality of life in colorectal cancer survivors Cover

Gender impact on quality of life in colorectal cancer survivors

Open Access
|Apr 2025

Figures & Tables

Figure 1.

Mean scores between males and females in the standardized quality of life questionnaires of European Organization for Research and Treatment of Cancer (EORTC) named EORTC QLQ-30.
Mean scores between males and females in the standardized quality of life questionnaires of European Organization for Research and Treatment of Cancer (EORTC) named EORTC QLQ-30.

Figure 2.

Mean scores between males and females in the EORTC QLQ CR29 questionnaire.
CR29 = colorectal cancer 29; EORTC = European Organization for Research and Treatment of Cancer; QLQ = quality of life questionnaire
Mean scores between males and females in the EORTC QLQ CR29 questionnaire. CR29 = colorectal cancer 29; EORTC = European Organization for Research and Treatment of Cancer; QLQ = quality of life questionnaire

Socio-demographic and other characteristics of colorectal cancer patients, grouped by gender (n = 239)

VariablesTotal number (%)Male (%)Female (%)
Gender
  Male134 (56.1)
  Female105 (43.9)
Age
  30–393 (1.3)1 (0.7)2 (1.9)
  40–4922 (9.2)7 (5.2)15 (14.3)
  50–5946 (19.2)27 (20.1)19 (18.1)
  60–6968 (28.5)49 (36.6)19 (18.1)
  70–7961 (25.5)28 (20.9)33 (31.4)
  80–89+39 (16.3)22 (16.4)17 (16.2)
Education
  Unfinished primary school8 (3.4)4 (3.0)4 (3.8)
  Primary education43 (18)16 (11.9)27 (25.7)
  Secondary education138 (57.8)86 (64.2)52 (49.5)
  Higher education / university degree43 (18)25 (18.7)18 (17.1)
  Master’s degree / Ph.D.7 (3)3 (2.2)4 (3.8)
Marital status
  Divorced11 (4.7)8 (6.0)3 (2.9)
  Married or common-law167 (70.2)101 (75.9)66 (62.9)
  Single22 (9.2)15 (11.3)7 (6.7)
  Widowed38 (16)9 (6.8)29 (27.6)
Primary location
  Colon (C18) or rectosigmoid junction (C19)114 (47.7)54 (40.3)60 (57.1)
  Rectum (C20)125 (52.3)80 (59.7)45 (42.9)
TNM staging
  Stage I41 (17.2)21 (15.7)20 (19.0)
  Stage II53 (22.2)21 (15.7)32 (30.5)
  Stage III145 (60.7)92 (68.7)53 (50.5)
Treatment
  Surgical treatment92 (38.5)40 (29.9)52 (49.5)
  Combination of radiation and surgery21 (8.9)13 (9.7)8 (7.6)
  Combination of radiation, systemic and surgical treatment96 (40.2)68 (50.8)28 (26.7)
  Combination of systemic and surgical treatment30 (12.6)13 (9.7)17 (16.2)

Mean scores with standard deviations, compare differences between two independent groups with Mann-Whitney U-test for all scales of the EORTC QLQ C30 for CRC patients by gender

TotalMaleFemaleUp
MSSDMSSDMSSD
Global health status/QoL68.820.169.820.167.420.36660.50.474
Physical functioning8518.086.417.883.318.260750.064
Role functioning82.524.781.726.283.522.770300.992
Emotional functioning86.517.189.414.782.819.35446.50.002
Cognitive functioning90.115.392.011.987.618.662940.109
Social functioning83.922.184.720.882.923.669070.791
Fatigue18.120.314.318.523.121.45179<0.001
Nausea/vomiting1.35.40.42.52.47.56449.50.007
Pain13.320.611.719.915.221.36314.50.122
Dyspnea4.211.93.511.15.112.96668.50.286
Insomnia20.828.116.424.426.331.65884.50.015
Appetite loss6.115.94.212.58.619.163980.053
Constipation8.217.97.014.89.821.168020.531
Diarrhea8.617.38.716.38.618.56861.50.653
Financial problems12.124.411.023.813.425.26520.50.315

Mean scores with standard deviations, compare differences between two independent groups with Mann-Whitney U-test for all scales of the EORTC QLQ CR29 for CRC patients by gender

TotalMaleFemaleUp
MSSDMSSDMSSD
Body image87.221.990.018.583.725.36094.50.047
Anxiety62.127.965.926.057.229.55979.50.029
Weight83.525.587.322.378.728.55879.50.010
Sexual function (men)35.926.635.926.6
Sexual function (women)17.221.9 17.221.9
Urinary frequency24.623.525.723.623.223.365980.394
Blood and mucus in stool2.97.62.77.43.07.969690.835
Stool frequency*12.017.013.817.89.615.76019.50.045
Urinary incontinence9.520.68.020.111.421.16330.50.064
Dysuria3.913.45.414.81.911.26311.50.008
Abdominal pain10.018.19.417.610.818.868380.628
Buttock pain9.819.510.420.28.918.667890.532
Bloated feeling17.622.215.720.720.023.864070.179
Dry mouth14.521.914.921.114.023.06707.50.463
Hair loss2.710.91.89.53.812.565850.073
Taste5.914.16.013.55.714.96859.50.602
Flatulence*23.824.522.424.125.725.065280.293
Faecal incontinence*13.422.815.924.410.320.361480.055
Sore skin*13.523.013.922.913.023.368440.657
Embarrassment*14.926.714.626.115.227.567920.989
Stoma care problems14.826.611.422.320.031.94180.321
Impotence31.230.231.230.2
Dyspareunia10.924.5 10.924.5
DOI: https://doi.org/10.2478/raon-2025-0023 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 457 - 465
Submitted on: Nov 1, 2024
Accepted on: Feb 22, 2025
Published on: Apr 11, 2025
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Aleksandra Grbic, Majda Causevic, Sara Brodaric, Mojca Birk, Irena Oblak, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.